| | Atherothrombosis | | | Prevent The Event: Defining The Role of Oral Antiplatelet Therapy in Atherothrombosis
Overview
Atherothrombosis is the leading cause of death worldwide and the underlying process in the etiology of acute coronary syndrome (ACS), stroke and vascular death. Cardiovascular risk factors such as obesity, the metabolic syndrome, diabetes mellitus, hypertension, smoking and other "lifestyle" risks contribute to this pandemic of atherothrombotic disease. Patients with ACS, stroke/TIA and PAD (peripheral arterial disease), present major challenges to the primary care clinician in terms of managing CV risk factors and prevention of a second event. This lecture will overview current studies and treatment guidelines for PAD, ACS and Stroke and explore the role of primary care in long-term treatment of these patients.
Objectives
Describe 3 clinical conditions in which dual antiplatelet therapy is recommended
Name 5 treatment recommendations for reduction of global CV risk
Faculty
Theodore G. Ganiats, MD
Professor and Interim Chair,
Department of Family and Preventive Medicine,
University of California San Diego,
Executive Director UCSD Health Outcomes Assessment Program
San Diego, CA
Robert Schainfeld, DO
Associate Director, Vascular Medicine
Massachusetts General Hospital
Boston, MA
| | | Smoking Cessation | | | Do Ask, Do Tell: Successful Smoking Interventions
Overview
Smoking is the single most important preventable cause of death in the United States. This session, "Do Ask, Do Tell: Successful Smoking Interventions", will address practical ways primary care clinicians can help their patients quit smoking.
Objectives
Screen all patients for smoking status and design individualized cessation interventions for patients who smoke
Commit to active follow-up with patients along the smoking cessation path
Faculty
Lesley A. Schroeder, MD
Associate Clinical Professor
Department of Psychiatry & Behavioral Sciences
University of CA-Davis
Sacramento, CA
| | | Sleep-Wake | | | Do Patients with Sleep-Wake Disorders Keep YOU up at Night? Strategies for Identifying and Managing Patients with a "Sleep Debt"
Overview
The diagnosis, treatment, and on-going management of patients with sleep disorders, which affect 21% of the population, are most commonly the responsibility of the primary care clinician. Utilizing effective screening tools, distinguishing primary versus secondary sleep disorders, recognizing comorbid conditions, and developing a treatment strategy based on individual patient factors can all present as challenges. This activity will provide the information and case-based scenarios to maximize outcomes for patients with sleep disorders.
Objectives
Integrate the use of screening tools to differentiate primary versus secondary sleep disorders
Identify the treatment strategies based on individual patient factors and characteristics
Faculty
Joseph A. Lieberman III, MD, MPH
Professor of Family Medicine
Jefferson Medical College
Thomas Jefferson University
Associate Editor, Delaware Medical Journal
Philadelphia, PA
Michael J. Thorpy, MD
Professor of Neurology
Albert Einstein College of Medicine
Bronx, NY
| | | Migraine | | | Diagnosis and Effective Treatment of Migraine to Limit Allodynia and Progression to Chronic Headache
Overview
This educational activity will describe and reinforce tools that enable clinicians to efficiently recognize and diagnose migraine that may have been previously undiagnosed and untreated, or who may have lapsed from treatment, and to communicate realistic treatment goals to reach the goal of improved patient outcomes.
Objectives
Identify the symptoms and patterns of headache for accurate assessment of migraine, including associated risks for progression to chronic migraine, and utilize simple screening tools to overcome diagnostic challenges
Create a migraine management strategy tailored to individual patient needs that incorporates a stratified approach to pharmacological and nonpharmacological therapies and communication of realistic treatment goals to help improve patient outcomes
Faculty
Frederick R. Taylor, MD, FAHS
Adjunct Professor of Neurology
University of Minnesota School of Medicine
Director, Park Nicollet Headache Clinic and Research Center
Minneapolis, MN
M. Susan Burke, MD, FACP
Clinical Assistant Professor of Medicine
Thomas Jefferson University
Philadelphia, PA
Director, Internal Medicine Clinical Care Center
Lankenau Hospital
Wynnewood, PA
| | | Adult Vaccines | | | Adult Immunizations: Overcoming Obstacles in Primary Care
Overview
Despite the great advances in medical care represented by adult immunization, the challenges continue to be numerous and varied. This activity will explore the barriers, clarify the "myths," and provide the most updated information on adult vaccines to increase immunization rates.
Objectives
Identify the Advisory Committee on Immunization Practices (ACIP) recommended adult vaccines and the recommended immunization schedules for each ACIP recommended adult vaccine
Increase knowledge and confidence regarding safety, risks, benefits, and side effects of adult immunizations and create a strategy to increase patient immunization rates, including the use of a health maintenance form or other tool for immunization review
Faculty
Sharon G. Humiston, MD, MPH
Associate Professor of Emergency Medicine and Pediatrics
University of Rochester Medical Center
Rochester, NY
| | | Pulmonary Arterial Hypertension | | | Achieving More Ambitious Goals in Managing PAH in Primary Care
Overview
Updated American College of Chest Physicians guidelines acknowledge the pace with which medical therapies for pulmonary arterial hypertension (PAH) are evolving. This educational session will address the new guidelines, diagnostic and functional assessment, and options for lifestyle and pharmacologic therapy. The discussion will be applicable to primary care practitioners and provide them with the awareness, information and evidence based therapies used to manage PAH.
Objectives
Differentiate the hemodynamic abnormalities of pulmonary arterial hypertension including its etiology and pathogenesis in order to decrease morbidity and mortality of the patient population at risk.
Apply clinical practice guidelines in the early detection and effective management of PAH by selecting appropriate therapeutic interventions to attain therapeutic goals for patients with PAH.
Faculty
Myung H. Park, MD
Director, Pulmonary Vascular Diseases Program
Assistant Professor of Medicine
University of Maryland School of Medicine
Baltimore, MD
Mathew M. Clark, MD, MA
Associate Clinical Professor, Family and Community Medicine
Temple University School of Medicine
Philadelphia, PA
| | | Gout | | | Front-line Management of Gout: A Step-by-Step Guide to Best Practice
Overview
This program will address the key "must-know" points in gout management. The provision of case-based presentations will provide primary care clinicians with a clear step-by-step comprehension of how to manage gout and establish effective, supportive patient interaction to optimize life-long adherence to life-style and therapeutic regimens. There will be opportunities to interact with the faculty and obtain their expert opinions on clinical issues faced in managing patients with gout.
Objectives
Identify that the long-term goal of gout treatment is to reduce serum urate to <6.0 mg/dL and to define the key steps in selecting and individualizing urate lowering therapy according to the disease stage; together with recognizing the importance of monitoring serum urate levels
Educate patients that an important factor in successful management includes their long-term commitment to adherence with the recommended life-style and drug interventions
Faculty
D. Wayne Bell, MD
Family Practitioner
Bowling Green Family Care Center
Medical Director, Diabetes Day Care Center
Wood County Hospital
Bowling Green, OH
Brian Mandell, MD, PhD, FACP, FACR
Professor and Chairman of Medicine
CCF Lerner College of Medicine of CWRU
Center for Vasculitis Care and Research
Editor in Chief, Cleveland Clinic of Medicine
The Cleveland Clinic
Cleveland, OH
| | | Enhancing Female Sexuality | | | Enhancing Female Sexuality
Overview
This program will address the need for improved communication between the clinician and the patient in the area of sexual health, providing communication techniques for the clinician to overcome the barriers that occur with discussing this issue with patients. In addition, the program will provide treatment options for preventing genital atrophy and enhancing libido.
Objectives
Define the major factors of female sexual dysfunction including the role of estrogen deficiency in genital atrophy
Develop communication skills that will improve discussions of sexual health issues with patients
Faculty
Murray A. Freedman, MS, MD
Clinical Professor
Department of Obstetrics and Gynecology
Medical College of Georgia
Augusta, GA
| | | Opioid Therapy | | | Opioid Therapy for Patients with Pain: Strategies for Risk Assessment and Management
Overview
Opioids provide effective pain management for acute and cancer pain and are useful in treating patients with chronic non-cancer pain who have not responded to other pain management therapies. Because of potential opioid abuse, patients and physicians may be reluctant to initiate opioid therapy for pain relief. This program will examine clinical strategies and recently published guidelines to balance effective opioid therapy against the risk of opioid misuse, abuse, and diversion.
Objectives
Implement clinical strategies designed to provide safe and effective use of opioid therapy while addressing the issues of opioid abuse, misuse, and diversion
Utilize recommendations from the American Pain Society/American Academy of Pain Medicine's Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain in clinical practice
Faculty
Howard Heit, MD
Board Certified in Internal Medicine and
Gastroenterology/Hepatology
Diplomat in Addiction Medicine
Certified Medical Review Officer
Chronic Pain Specialist
Assistant Clinical Professor
Georgetown University
Washington, DC
|
|
